Lazurite™ was named one of the 100 Best Healthcare Technology Companies of 2022 by the Healthcare Technology Report

CLEVELAND–(BUSINESS WIRE)–Lazurite™ was selected as one of the Top 100 Healthcare Technology Companies of 2022 by The Healthcare Technology Report. The Healthcare Technology Report (“The Report”) provides market research and insights, business news, investment activity updates and key company information on healthcare technology developments.

“The award winners on this year’s list represent the absolute best in the field of health technology,” reads The Report’s announcement. “These companies are changing the face of the industry. They use their considerable talent to find innovative solutions to the most pressing public health problems, saving countless lives and extending health spans in the process.”

Lazurite is a medical device startup backed by private capital. The Cleveland-based company develops devices to set new operating room standards for efficiency and patient safety. Lazurite’s ArthroFree™ system is the first wireless surgical camera system to receive FDA market clearance for arthroscopy and general endoscopy.

“We are proud to be recognized by the Healthcare Technology Report for our ArthroFree System,” said Eugene Malinskiy, CEO and co-founder of Lazurite. “The ArthroFree system ushers in a new era of wireless surgical visualization in minimally invasive surgery. It was designed to meet the needs of surgeons looking for state-of-the-art surgical tools that allow them to operate more quickly and effectively.”

By eliminating the cables that tie the surgeon to the operating tower in a traditional system, the ArthroFree system allows for more ergonomic and efficient surgical movements. These cables impede the surgeon and expose surgical staff to the risk of tripping and falling. They also require staff time to set up, dismantle and clean properly, and they have been involved in operating room fires and patient burns.

“This year’s top 100 companies represent a range of disciplines, from genomics to pharmaceuticals, laboratory testing, therapeutics, data analytics and more,” The Report said in its announcement. “What they have in common is the impact they make on patients’ lives, whether through direct treatment or by providing advanced, breakthrough products and services to treatment providers. They drive the industry forward and create an environment where better care is possible for everyone. Please join us to celebrate the Top 100 Healthcare Technology Companies of 2022.”

Check out the full list of the Top 100 Healthcare Technology Companies of 2022

About the Healthcare Technology Report

The Healthcare Technology Report provides market research and insights, business news, investment activity updates and major company developments related to the Healthcare Technology sector. Based in New York City, the company is led by an experienced team of editors, writers, and media professionals with a deep understanding of healthcare technology and the diverse companies, executives, and investors that make up the sector.

About Lasurit

Lazurite™ is a pre-sales medical device startup backed by private capital. The company has raised more than $25 million to date from institutional investors, family offices and more than 70 champion physicians. The Cleveland-based company (founded 2015) develops devices to set new OR standards for efficiency and patient safety. Lazurite’s ArthroFree™ system is the first wireless surgical camera system to receive FDA market clearance for arthroscopy and general endoscopy. The ArthroFree system ushers in a new era of wireless surgical visualization in minimally invasive surgery. It was designed to meet the needs of surgeons looking for more maneuverable, state-of-the-art surgical tools. Lazurite’s current product pipeline includes devices incorporating their patented camera technology and laser light technology. Lazurite’s technologies are protected by an extensive intellectual property portfolio that includes the ArthroFree wireless surgical camera system and the novel Meridiem™ light source, as well as other products currently in development. For more information, visit: https://lazurite.co.

Forward-Looking Statements

This press release contains “forward-looking statements.” Forward-looking statements are identifiable by words such as “anticipate”, “intend”, “plan”, “believe”, “project”, “estimate”, “expect”, “may”, “should”, “become”, “designed”. ”, “milestone” and similar references to future periods. Examples of forward-looking statements include, but are not limited to, statements we make regarding the anticipated impact of the ArthroFree System on the field of minimally invasive surgery, particularly arthroscopic surgery, and our future sales of the ArthroFree System. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, forecasts, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they involve inherent uncertainties, risks and changes in circumstances that are difficult to predict, many of which are beyond our control. Our actual results could differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on these forward-looking statements. Any forward-looking statement we make in this press release is based only on information currently available to us and speaks only as of the date of this release. We undertake no obligation to publicly update any forward-looking statements, whether written or oral, made from time to time, whether as a result of new information, future developments or otherwise.

Lazurite™, ArthroFree™ and Meridiem™ are trademarks of Lazurite Holdings LLC.

media center

Visit lazurite.co/media for videos, logos, images, data sheets, bios and more.

Comments are closed.